| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Adefovir | Adefovir Dipivoxil Impurity 1 | VL5400021 | View CAS 1215101-40-8 |
| Adefovir | Adefovir Dipivoxil Impurity 10 (Mono-POM Methyl Adefovir) | VL5400009 | View CAS 1875153-79-9 |
| Adefovir | Adefovir Dipivoxyl Impurity I | VL5400020 | View |
| Adefovir | Adefovir Disoproxil Dimer Impurity | VE009375 | View CAS 323201-05-4 |
| Adefovir | Adefovir Monopivoxil | VL5400023 | View CAS 142341-05-7 |
| Catalogue No. | VL5400021 |
| CAS No. | 1215101-40-8 |
| Molecular Formula | C25H40N5O8P |
| Molecular Weight | 569.587561 g/mol |
| Parent drug | Adefovir |
| IUPAC Name | ((((2-(6-pivalamido-9H-purin-9-yl)ethoxy)methyl)phosphinediyl)bis(oxy))bis(methylene) bis(2, 2-dimethylpropanoate) |
| Synonyms | N/A |
| References | Gao, Yuan, et al. “Coformer Selection Based on Degradation Pathway of Drugs: A Case Study of Adefovir Dipivoxil–Saccharin and Adefovir Dipivoxil–Nicotinamide Cocrystals.” International Journal of Pharmaceutics, vol. 438, no. 1-2, Nov. 2012, pp. 327–35, https://doi.org/10.1016/j.ijpharm.2012.09.027. Yuan, Lung-Chi. Pharmaceutical Research, vol. 17, no. 9, 2000, pp. 1098–103, https://doi.org/10.1023/a:1026457729708. |
| Status | In-stock |
| ListName | Adefovir Dipivoxil Impurity 1 |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
